La Jolla Pharmaceutical Co
Innoviva Completes Acquisition of La Jolla Pharmaceutical At Average Price Of $6.23 Per Share
Innoviva, Inc. (NASDAQ:INVA) ("Innoviva"), a diversified holding company with a portfolio of royalties and a growing portfolio of innovative healthcare assets, today announced that its tender offer to purchase
Benzinga · 08/22/2022 13:00
BRIEF-La Jolla Institute For Immunology Acquires The Carterra LSA Platform
BRIEF-La Jolla Institute For Immunology Acquires The Carterra LSA Platform
Reuters · 08/01/2022 12:10
Biotech M&A returns as Vertex, Innoviva make buys
Come, thou long-expected M&A. On Monday, Vertex Pharmaceuticals Inc. and Innoviva Inc. both announced that they were making acquisitions. Vertex (Nasdaq: VRTX) is set to buy ViaCyte, a cell therapy startup specializing in diabetes, for $320 million cash,...
American City Business Journals · 07/12/2022 17:35
How this Peninsula company is turning lung drug royalties into acquisitions
With the help of nearly $400 million in royalties from a well-known drug targeting asthma and COPD, the company wrapped up one acquisition and launched another.
American City Business Journals · 07/11/2022 21:07
5 Top Short Squeeze Stocks to Watch This Week
Investor Place · 07/11/2022 15:46
La Jolla Pharmaceutical (LJPC) Stock Skyrockets on Innoviva Acquisition News
Investor Place · 07/11/2022 15:15
Why U.S. Stocks Are Trading Lower; AZZ Earnings And More
U.S. stocks traded lower this morning as investors digested the recent jobs report for the month of June.
Benzinga · 07/11/2022 14:55
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 07/11/2022 12:37

Webull offers kinds of La Jolla Pharmaceutical Co stock information, including NASDAQ:LJPC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LJPC stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading LJPC stock methods without spending real money on the virtual paper trading platform.